These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15839935)

  • 1. Effects of TAK-802, a novel acetylcholinesterase inhibitor, and tamsulosin, an alpha1-adrenoceptor antagonist, and their synergistic effects on the urodynamic characteristics in a guinea-pig model of functional bladder outlet obstruction.
    Nagabukuro H; Hashimoto T; Iwata M; Doi T
    BJU Int; 2005 May; 95(7):1071-6. PubMed ID: 15839935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of TAK-802, a novel acetylcholinesterase inhibitor, and various cholinomimetics on the urodynamic characteristics in anesthetized guinea pigs.
    Nagabukuro H; Okanishi S; Doi T
    Eur J Pharmacol; 2004 Jun; 494(2-3):225-32. PubMed ID: 15212979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical comparison of selective and non-selective alpha 1A-adrenoceptor antagonists for bladder outlet obstruction associated with benign prostatic hyperplasia: studies on tamsulosin and terazosin in Chinese patients. The Chinese Tamsulosin Study Group.
    Na YJ; Guo YL; Gu FL
    J Med; 1998; 29(5-6):289-304. PubMed ID: 10503165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.
    Nishino Y; Masue T; Miwa K; Takahashi Y; Ishihara S; Deguchi T
    BJU Int; 2006 Apr; 97(4):747-51, discussion 751. PubMed ID: 16536766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of combined treatment of tadalafil and tamsulosin on bladder dysfunction via the inhibition of afferent nerve activities in a rat model of bladder outlet obstruction.
    Furuta A; Suzuki Y; Igarashi T; Koike Y; Egawa S; Yoshimura N
    Int Urol Nephrol; 2018 May; 50(5):839-844. PubMed ID: 29520560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamsulosin in men with confirmed bladder outlet obstruction: a clinical and urodynamic analysis from a single centre in New Zealand.
    Arnold EP
    BJU Int; 2001 Jan; 87(1):24-30. PubMed ID: 11121988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of the combination of an alpha1-blocker with an anticholinergic agent in the treatment of lower urinary tract symptoms associated with bladder outlet obstruction.
    Athanasopoulos A; Perimenis P
    Expert Opin Pharmacother; 2005 Nov; 6(14):2429-33. PubMed ID: 16259574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the selective acetylcholinesterase inhibitor TAK-802 on the voiding behavior and bladder mass increase in rats with partial bladder outlet obstruction.
    Hashimoto T; Nagabukuro H; Doi T
    J Urol; 2005 Sep; 174(3):1137-41. PubMed ID: 16094081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tamsulosin on spontaneous bladder contraction in conscious rats with bladder outlet obstruction: comparison with effect on intraurethral pressure.
    Ohtake A; Ukai M; Saitoh C; Sonoda R; Noguchi Y; Okutsu H; Yuyama H; Sato S; Sasamata M; Miyata K
    Eur J Pharmacol; 2006 Sep; 545(2-3):185-91. PubMed ID: 16887117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-blocker test: alternative to pressure-flow study of bladder outlet obstruction and detrusor contractility in patients without an enlarged prostate.
    Hirayama A; Samma S; Yamaguchi A; Fukui Y; Matsumoto Y; Fujimoto K; Hirao Y
    Int J Urol; 2004 Jan; 11(1):20-5. PubMed ID: 14678180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower urinary tract symptoms/benign prostatic hyperplasia: fast control of the patient's quality of life.
    Djavan B
    Urology; 2003 Sep; 62(3 Suppl 1):6-14. PubMed ID: 12957195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urodynamic effects of alpha1-blocker tamsulosin on voiding dysfunction in patients with neurogenic bladder.
    Kakizaki H; Ameda K; Kobayashi S; Tanaka H; Shibata T; Koyanagi T
    Int J Urol; 2003 Nov; 10(11):576-81. PubMed ID: 14633081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dutasteride add-on therapy reduces detrusor mass in patients with benign prostatic enlargement not satisfied with alpha-adrenergic antagonist monotherapy: A single center prospective study.
    De Nunzio C; Brassetti A; Proietti F; Gacci M; Serni S; Esperto F; Tubaro A
    Neurourol Urodyn; 2017 Nov; 36(8):2096-2100. PubMed ID: 28257560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of tamsulosin hydrochloride on bladder outlet obstruction associated with benign prostatic hyperplasia: effect on urethral pressure profile and cystometrogram].
    Murayama K; Katsumi T; Tajika E; Kawaguchi K; Ueki O
    Hinyokika Kiyo; 1997 Nov; 43(11):799-803. PubMed ID: 9436025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamsulosin, a selective alpha 1c-adrenoceptor antagonist: a randomized, controlled trial in patients with benign prostatic 'obstruction' (symptomatic BPH). The European Tamsulosin Study Group.
    Abrams P; Schulman CC; Vaage S
    Br J Urol; 1995 Sep; 76(3):325-36. PubMed ID: 7551841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of tamsulosin with alfuzosin in the treatment of patients with lower urinary tract symptoms suggestive of bladder outlet obstruction (symptomatic benign prostatic hyperplasia). The European Tamsulosin Study Group.
    Buzelin JM; Fonteyne E; Kontturi M; Witjes WP; Khan A
    Br J Urol; 1997 Oct; 80(4):597-605. PubMed ID: 9352699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamsulosin for benign prostatic hyperplasia.
    Wilt TJ; Mac Donald R; Rutks I
    Cochrane Database Syst Rev; 2003; (1):CD002081. PubMed ID: 12535426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
    Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
    BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urodynamic effects of dutasteride add-on therapy to alpha-adrenergic antagonist for patients with benign prostatic enlargement: prospective pressure-flow study.
    Wada N; Kita M; Hashizume K; Matsumoto S; Kakizaki H
    Neurourol Urodyn; 2013 Nov; 32(8):1123-7. PubMed ID: 23861329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased contractile response to phenylephrine in detrusor of patients with bladder outlet obstruction: effect of the alpha1A and alpha1D-adrenergic receptor antagonist tamsulosin.
    Bouchelouche K; Andersen L; Alvarez S; Nordling J; Bouchelouche P
    J Urol; 2005 Feb; 173(2):657-61. PubMed ID: 15643283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.